Covid-19 Research

Commentary

Predictive Pathologic Features of Nodal Metastasis and Tumor Recurrence in HPV-Associated Endocervical Adenocarcinoma

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Commentary
Subject Medicine Group
OCLC JBRES Record
Yue Wang and Wenxin Zheng*
Issue: Volume5-Issue6
Pages: 576-579
Received: 2024-06-10
Accepted: 2024-06-13
Published: 2024-06-14

Abstract

Endocervical Adenocarcinoma (EAC) is the second most prevalent malignancy of the uterine cervix, with a significant portion linked to high-risk HPV infection [1]. The incidence of EAC has risen notably, now accounting for up to 25% of new cervical cancer diagnoses at 1.44/100,000 women in the United States [2]. Overall survival is mainly related to the FIGO (International Federation of Gynecology and Obstetrics) stage with decreased survival in advanced staging.

FullText HTML FullText PDF DOI: 10.37871/jbres1928 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2024 Wang Y, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Wang Y, Zheng W. Predictive Pathologic Features of Nodal Metastasis and Tumor Recurrence in HPV-Associated Endocervical Adenocarcinoma. J Biomed Res Environ Sci. 2024 Jun 14; 5(6): 576-579. doi: 10.37871/jbres1928, Article ID: JBRES1928, Available at: https://www.jelsciences.com/articles/jbres1928.pdf

Subject area(s)

OncologyCancerPathology

References

  1. Stolnicu S, Hoang L, Chiu D, Hanko-Bauer O, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Oliva E, Park KJ, Abu-Rustum NR, Soslow RA. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC). Am J Surg Pathol. 2019 Apr;43(4):466-474. doi: 10.1097/PAS.0000000000001224. PMID: 30720532; PMCID: PMC6417947.
  2. Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health (Larchmt). 2012 Oct;21(10):1031-7. doi: 10.1089/jwh.2011.3385. Epub 2012 Jul 20. PMID: 22816437; PMCID: PMC3521146.
  3. Huang Z, Mayr NA, Gao M, Lo SS, Wang JZ, Jia G, Yuh WT. Onset time of tumor repopulation for cervical cancer: first evidence from clinical data. Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):478-84. doi: 10.1016/j.ijrobp.2011.12.037. Epub 2012 Mar 2. PMID: 22386374; PMCID: PMC3369115.
  4. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr, Alberts DS. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000 Apr;18(8):1606-13. doi: 10.1200/JCO.2000.18.8.1606. Corrected and republished in: J Clin Oncol. 2023 Oct 10;41(29):4605-4612. doi: 10.1200/JCO.22.02769. PMID: 10764420.
  5. Balega J, Michael H, Hurteau J, Moore DH, Santiesteban J, Sutton GP, Look KY. The risk of nodal metastasis in early adenocarcinoma of the uterine cervix. Int J Gynecol Cancer. 2004 Jan-Feb;14(1):104-9. doi: 10.1111/j.1048-891x.2004.14079.x. PMID: 14764037.
  6. Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer. 2000 Jul;10(4):305-312. doi: 10.1046/j.1525-1438.2000.010004305.x. PMID: 11240691.
  7. Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix. Am J Surg Pathol. 2018 Feb;42(2):214-226. doi: 10.1097/PAS.0000000000000986. PMID: 29135516; PMCID: PMC5762258.
  8. Khalil J, Bellefqih S, Sahli N, Afif M, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N. Impact of cervical cancer on quality of life: beyond the short term (Results from a single institution): Quality of life in long-term cervical cancer survivors: results from a single institution. Gynecol Oncol Res Pract. 2015 Sep 19;2:7. doi: 10.1186/s40661-015-0011-4. PMID: 27231567; PMCID: PMC4880873.
  9. Nola M, Tomicic I, Dotlic S, Morovic A, Petrovecki M, Jukic S. Adenocarcinoma of uterine cervix -- prognostic significance of clinicopathologic parameters. Croat Med J. 2005 Jun;46(3):397-403. PMID: 15861518.
  10. Diaz De Vivar A, Roma AA, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Arville B, Teramoto N, Ali-Fehmi R, Rutgers JK, Tabassum F, Barbuto D, Aguilera-Barrantes I, Shaye-Brown A, Daya D, Silva EG. Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study. Int J Gynecol Pathol. 2013 Nov;32(6):592-601. doi: 10.1097/PGP.0b013e31829952c6. PMID: 24071876.
  11. Roma AA, Mistretta TA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, Mikami Y, Hong SR, Teramoto N, Ali-Fehmi R, Barbuto D, Rutgers JK, Silva EG. New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome. Gynecol Oncol. 2016 Apr;141(1):36-42. doi: 10.1016/j.ygyno.2016.02.028. PMID: 27016227; PMCID: PMC5068220.
  12. Roma AA, Park KJ, Xie H, De Vivar AD, Alvarado-Cabrero I, Rutgers JKL, Barbuto D, Silva EG. Role of Lymphovascular Invasion in Pattern C Invasive Endocervical Adenocarcinoma. Am J Surg Pathol. 2017 Sep;41(9):1205-1211. doi: 10.1097/PAS.0000000000000822. PMID: 28614201.
  13. Holloway SB, Colon GR, Zheng W, Lea JS. Tumor Necrotic Debris and High Nuclear Grade: Newly Identified High-risk Factors for Early-stage Endocervical Adenocarcinoma. Am J Clin Oncol. 2021 Apr 1;44(4):162-168. doi: 10.1097/COC.0000000000000798. PMID: 33606367.
  14. Rivera-Colon G, Chen H, Niu S, Lucas E, Holloway S, Carrick K, Gwin K, Lea J, Zheng W. Cervical Adenocarcinoma: Histopathologic Features From Biopsies to Predict Tumor Behavior. Am J Surg Pathol. 2020 Feb;44(2):247-254. doi: 10.1097/PAS.0000000000001379. PMID: 31567190.
  15. Yu J, Liu YY, Zhao JJ, Li SX, Zhu HT. [The value of morphological characteristics of cervical adenocarcinoma biopsy tissue in predicting tumor invasion pattern and prognosis]. Zhonghua Bing Li Xue Za Zhi. 2020 Dec 8;49(12):1300-1304. Chinese. doi: 10.3760/cma.j.cn112151-20200318-00222. PMID: 33287517.
  16. Wang Y, Chang RJ, Luo RZ, Yu J, Zhang X, Yang X, Quddus MR, Li L, Yang W, Liu A, Jiang Q, Zhao R, Zhu H, Zhou F, Wang Y, Sheng X, Liu LL, Wen YL, Banet N, Sung CJ, Qi Y, Bi R, Li M, Wang Y, Li J, Lin W, Wang Y, Rivera G, Chen H, Holloway SB, Fadare O, Liu J, Wang J, Lea J, Kong B, Zheng W. Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study. Am J Surg Pathol. 2022 May 1;46(5):713-724. doi: 10.1097/PAS.0000000000001833. PMID: 34753864.
  17. Ceballos KM, Shaw D, Daya D. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis. Am J Surg Pathol. 2006 Mar;30(3):370-4. doi: 10.1097/01.pas.0000186398.18206.ff. PMID: 16538058.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership